TRIM28作为SUMO结合酶对SUMO酸TRAF6的功能,并调节HBV复制细胞中的NF-κB激活
Yanfang Yang1,2, Tao Wang1,2, Yuyin Fu3
1Department of Central Laboratory, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Hepatology international
|February 7, 2025
概括
SUMO结合酶TRIM28修改了TRAF6的SUMOylation,影响了NF-κB的激活和B型肝炎病毒 (HBV) 的复制. 这一发现为抗HBV治疗提供了新的策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乙型肝炎病毒 (HBV) 构成了严重的健康威胁.
- 在病毒感染和癌症中SUMOylation的作用还未得到充分研究.
- 瘤亡因子受体相关因子6 (TRAF6) 是NF-κB通路的关键.
研究的目的:
- 研究TRIM28在调节TRAF6SUMOylation中的作用.
- 阐明SUMOylation在HBV复制和抗病毒防御中的机制.
- 探索HBV感染的潜在治疗点.
主要方法:
- 免疫沉和西部斑点检测SUMOylated TRAF6.6的检测.
- 使用LC-MS/MS来识别TRAF6-TRIM28的相互作用.
- 位点定向的突变发生,以分析TRAF6 SUMOylation.
- 免疫组织化学和免疫光学用于蛋白质表达和定位.
- 在体内功能研究的HBV小鼠模型.
主要成果:
- 在HBV复制细胞中,SUMO1修饰的TRAF6水平增加.
- 氨酸453 (K453) 是一个主要的SUMO1修改站点在TRAF6.
- TRIM28催化了TRAF6的SUMOylation,从而对抗了它的无处不在.
- 通过减弱TRAF6介导的NF-κB激活,TRIM28过度表达抑制了HBV复制.
结论:
- 通过TRIM28介导的TRAF6的SUMOylation调节NF-κB的激活和HBV的复制.
- 这种SUMOylation机制为HBV感染期间的炎症反应提供了新的见解.
- TRIM28-TRAF6 SUMOylation 是开发抗HBV策略的一个潜在目标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
General Transcription Factors
5.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.1K


